Restatement
- Sector
- Healthcare
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Exchange
- Nasdaq
- State of incorporation
- DE
- Form
- 8-K
- Filed
- June 19, 2018
Filings & documents
Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.
Source filing ↗8-K · the filing we parseAll documents in this filing ↗accession 0001493152-18-008949Q/C TECHNOLOGIES, INC. — all SEC filings ↗EDGAR company page
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.